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In France, through exhaustive active surveillance, 
≈17.1 million adult cattle were tested for bovine spongiform 
encephalopathy from July 2001 through July 2007; ≈3.6 mil-
lion were >8 years of age. Our retrospective Western blot 
study of all 645 conﬁ  rmed cases found that 7 were H-type 
and 6 were L-type. 
M
ost cases of bovine spongiform encephalopathy 
(BSE) have shown strikingly uniform features. The 
origin of epidemics, mainly in the United Kingdom but 
to a lesser extent in other countries, has been foodborne 
contamination by a single major strain of the transmis-
sible spongiform encephalopathy (TSE) agent (1,2). 
However, in recent years, 2 distinct forms of the disease 
have been described; these forms deviate phenotypically 
from the previously identiﬁ  ed classic BSE (C-type) (3,4). 
Western blot studies of the protease-resistant prion pro-
tein (PrPres) showed higher and lower molecular masses 
of unglycosylated PrPres in these 2 types, subsequently 
named H-type and L-type compared with C-type BSE (5). 
In L-type BSE, the most discriminant molecular feature 
was the lower level of diglycosylated PrPres (4,5). Such 
cases have now been identiﬁ  ed in a number of different 
countries (6–8).
The origin of H-type and L-type BSE cases is unknown, 
but they may represent spontaneous or so-called sporadic 
forms of TSE, reminiscent of most cases of Creutzfeldt-Ja-
kob disease in humans. Transmission studies in wild-type 
mice (9) or in transgenic mice expressing the bovine PrP 
gene (5,10–12) have shown that the infectious agents in-
volved in H-type and L-type BSEs differ from the single 
strain isolated from C-type BSE.
Epidemiologic data are crucial to our understanding of 
the origin of such cases, but precise prevalence needs to be 
determined. The prevalence in cattle can now be assessed 
with accuracy because exhaustive BSE testing of adult cat-
tle was implemented in 2001 in all European member states 
(January 1 for abattoirs and July 1 for rendering plants). We 
report the results of a retrospective study to determine the 
frequency of H-type and L-type BSE identiﬁ  ed in France 
since July 2001.
The Study
A retrospective Western blot study was performed for 
all conﬁ  rmed BSE cases diagnosed in France after July 1, 
2001, as previously described (13). Brieﬂ  y, PrPres was 
extracted using the TeSeE Western blot conﬁ  rmatory as-
say (Bio-Rad, Marnes-la-Coquette, France) according to 
the manufacturer’s instructions. For immunoblotting, an-
tibodies RB1, 6H4 (R-Biopharm, St. Didier au Mont d’Or, 
France), Sha31 from the TeSeE Western blot (Bio-Rad), 
and SAF84 (kindly provided by J. Grassi, Commissariat 
Energie Atomique, Saclay, France) were used; these anti-
bodies recognize the bovine PrP sequences 110–113, 156–
164, 156–163, and 175–180, respectively. Two Western 
blot assays were conducted on the brainstem samples and 
used either an antibody against the PrP core (RB1, 6H4, or 
Sha31) or a C-terminal antibody (SAF84) (13). The charac-
teristics of H-type and L-type BSE (6,13) that were sought 
included 1) a higher or lower molecular mass of unglyco-
sylated PrPres with core antibodies in H-type and L-type 
BSE compared with C-type BSE, 2) a lower proportion 
of diglycosylated PrPres in L-type BSE, and 3) presence 
of an additional band at ≈14 kDa with SAF84 in H-type 
BSE. All cases with features of H-type or L-type BSE were 
then subjected to further Western blot analyses for detailed 
quantitative analysis of PrPres molecular features (appar-
ent molecular masses and glycoforms proportions).
Among the 645 BSE cases conﬁ  rmed between July 1, 
2001, and July 1, 2007, 7 H-type and 6 L-type isolates were 
identiﬁ  ed; these had occurred at a frequency of 0–3 H-type 
and 1 L-type case per year, compared with 6–219 cases of 
C-type BSE per year (Table). Molecular typing of 48 of 
these 645 samples was not possible because low levels of 
PrPres prevented detailed molecular characterization or be-
cause sample amount was insufﬁ  cient. All 13 atypical cases 
were detected in cattle >8 years of age, from fallen stock (9 
cases) or abattoir (4 cases); not 1 atypical case was found 
among the 98 BSE cases detected by clinical surveillance 
during this period. These 13 atypical cases were diagnosed 
by the different rapid BSE tests routinely used in France: 9 
by Prionics-Check Western, LIA, or Priostrip (AES, Com-
bourg, France), 3 by ELISA Bio-Rad, and 1 by IDEXX 
HerdChek (IDEXX Laboratories, Schiphol-Rijk, the Neth-
erlands). During retrospective interviews, the farmer and 
veterinarian for 6 of these animals reported clinical signs 
consistent with TSE in 3 fallen stock. This series of 13 cas-
es identiﬁ  ed since the beginning of exhaustive active sur-
veillance should be compared with a total of ≈17.1 million 
adult cattle tested, of which ≈3.6 million were >8 years of 
age. In addition to these 13 cases, the ﬁ  rst case of atypical 
(H-type) BSE was identiﬁ  ed in 2000, during an exhaustive 
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active surveillance program in rendering plants in a limited 
region of France.
The distribution of BSE-infected cattle by birth date 
(Figure 1) shows that 1 or 2 (H- or L-type cases) were 
eventually found positive by rapid tests of the brainstem in 
each annual birth cohort from 1986 through 1997, which 
compares with up to 221 cattle infected with C-type BSE 
born during 1990–2001 for which BSE was diagnosed dur-
ing 2001–2007. All H-type and L-type BSE cases showed 
similar features (Figure 2) regarding the high apparent 
molecular masses of unglycosylated PrPres (mean differ-
ence of ≈1 kDa using 6H4 antibody) for H-type BSE and 
lower levels of diglycosylated PrPres (mean difference of 
35% using 6H4 antibody) for L-type BSE, compared with 
C-type BSE. For L-type BSE cases, the differences in ap-
parent molecular masses were more obvious for the digly-
cosylated band (≈1-kDa difference using 6H4, compared 
with 0.3 kDa for the unglycosylated band), as previously 
observed (6). The ≈14-kDa band characteristic of H-type 
BSE was similarly detected in the 8 isolates with SAF84 
antibody but in none of the other cases classiﬁ  ed as L-type 
or C-type BSE.
Conclusions
This study involved exhaustive molecular typing of 
BSE cases during a given test period and in a country in 
which BSE testing has been mandatory for all adult slaugh-
tered or fallen cattle. France tests more animals than any 
other European country; ≈30% of the animals tested in 
the European Union are tested in France. The estimated 
frequency of H-type and L-type BSE was 0.41 and 0.35 
per million adult cattle tested, respectively (1.9 and 1.7 in 
cattle >8 years of age). Given the implementation dates of 
measures to control BSE and the birth dates of these BSE-
infected cattle, foodborne exposure to an infectious agent 
cannot be fully excluded for any of these cattle. However, 
the distribution of cattle affected by H- and L-type BSE, by 
year of birth, differs strikingly from that of cattle affected 
by C-type BSE and is consistent with the hypothesis that 
H-type and L-type BSE might represent sporadic prion dis-
orders. In comparison with another sporadic prion disease, 
the annual frequency of sporadic Creutzfeldt-Jakob disease 
in humans, which is estimated only by analyses of reported 
clinically suspect cases, is 1–2 cases per million. Similar 
studies in other countries, instead of those free of C-type 
BSE, would be useful. An alternative hypothesis to food-
borne contamination, such as contamination by a scrapie 
agent, cannot be fully excluded, as such contamination has 
been shown to be a risk factor for scrapie in sheep (14).
This study relied on the identiﬁ  cation of BSE cases 
by examination of the brainstem only, as derived from our 
knowledge of C-type BSE (15). We cannot exclude pos-
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Table. Results of retrospective molecular typing studies for types of bovine spongiform encephalopathy (BSE) cases identified, 
France, 2001–2007* 
Year  No. tested  Age >8 y  H-BSE  L-BSE  C-BSE  UC
2001 (Jul–Dec) 1,524,344 334,865  1  0  153 18 
2002 3,183,320  648,026  2  1  219  17 
2003 3,189,899  649,724  3  1  123  10 
2004 2,867,571  614,851  0  1  51  2 
2005 2,590,973  565,863  0  1  30  1 
2006  2,692,048  555,577  0 1 6 0 
2007 (Jan–Jun)  1,070,210  244,286  1 1 2 0 
Total 17,118,365  3,613,192  7  6  584  48 
*H-type, higher molecular masses of unglycosylated protease-resistant prion protein (PrPres); L-type, lower molecular masses of unglycosylated PrPres; 
C-type, classic BSE; UC, unclassified. 
Figure 1. Distribution of bovine 
spongiform encephalopathy cases 
identiﬁ  ed from July 1, 2001, through 
July 1, 2007, by year of cattle birth. 
H-type, higher molecular masses 
of unglycosylated protease-
resistant prion protein (PrPres); 
L-type, lower molecular masses 
of unglycosylated PrPres; C-type, 
classic BSE. sible differences in the pathogenesis of atypical BSEs that 
might result in underestimation of their frequency, e.g., in-
volvement of the brainstem at a later stage than with C-type 
BSE. This possibility is at least suggested by data available 
for L-type BSE, which shows a preferential distribution of 
abnormal PrP in more rostral brain regions (4,12). Stud-
ies of the pathogenesis of these novel BSE forms are thus 
important for understanding of prion disorders of domestic 
ruminant species.
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Figure 2. Representative Western blot analyses of protease-resistant 
prion protein (PrPres) in H-type (lanes 2, 3), L-type (lanes 5, 6), and 
C-type (lanes 1, 4, 7) cases of bovine spongiform encephalopathy 
(BSE). Bars to the left of the panels indicate the 29.0-, 20.1-, and 
14.3-kDa marker positions. H-type, higher molecular masses 
of unglycosylated PrPres; L-type, lower molecular masses of 
unglycosylated PrPres; C-type, classic BSE. Monoclonal antibodies 
Sha31 and SAF84 were used for PrPres detection in panels A and 
B, respectively.